Telehealth Assessment and Skill-Building Intervention for Stroke Caregivers (TASK III)
Launched by UNIVERSITY OF CINCINNATI · Mar 21, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The TASK III study is looking at how a special program can help family caregivers who are taking care of someone who has had a stroke. Caring for a loved one after a stroke can be tough, and this program aims to teach caregivers important skills to manage their loved one's care while also taking care of their own health. The study is currently recruiting participants, and caregivers between the ages of 65 and 74 who speak English and have access to a phone or computer may be eligible to join.
If you decide to participate, you would receive support through nine calls from a nurse, along with five interviews over time to gather information. To qualify, you need to be the main caregiver for someone recovering from a stroke at home and be able to communicate clearly by phone or computer. However, if the person you are caring for is in a nursing home, doesn't need help, or if you have certain health issues, you may not be eligible. This trial is an opportunity to gain skills and support that can make caregiving a bit easier while also focusing on your own well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary caregiver (family member or significant other providing care for a stroke survivor at home).
- • Fluent in the English language (i.e., able to read, speak, and understand English)
- • Access to telephone or computer.
- • No difficulties hearing or talking by telephone or computer.
- • Score 4 or more on a 6-item cognitive impairment screener.
- • Willing to participate in 9 calls from a nurse and 5 data collection interviews (Baseline, 8, 12, 24, 52).
- Exclusion Criteria:
- Excluded if the survivor:
- • Had not had a stroke.
- • Did not need help from the caregiver.
- • Resides in a nursing home or long-term care facility.
- Excluded if the caregiver or survivor is:
- • Under the age of 18 years.
- • Prisoner or on house arrest.
- • Pregnant.
- • Terminal illness (e.g., late stage cancer, end-of-life condition, renal failure requiring dialysis).
- • History of Alzheimer's, dementia, or severe mental illness (e.g., suicidal tendencies, schizophrenia, severe untreated depression or manic-depressive disorder).
- • History of hospitalization for alcohol or drug abuse within the past 5 years).
About University Of Cincinnati
The University of Cincinnati is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a robust focus on translational research, the university fosters a collaborative environment that integrates cutting-edge science with clinical practice. Its diverse team of experts, equipped with state-of-the-art facilities, is committed to exploring new therapeutic interventions aimed at improving patient outcomes. The University of Cincinnati actively engages in partnerships with industry and academia to drive forward-thinking solutions in medicine, ensuring that research findings are effectively translated into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cincinnati, Ohio, United States
Patients applied
Trial Officials
Tamilyn Bakas, PhD, RN
Principal Investigator
University of Cincinnati
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials